Open AccessSacubitril/Valsartan in the Treatment of Right Ventricular Dysfunction in Patients With Heart Failure With Reduced Ejection Fraction: A Real-world Study
Author(s) -
Ying Yang,
Chao Shen,
Jiangting Lu,
Guosheng Fu,
Chengliang Xiong
Publication year - 2021
Publication title -
journal of cardiovascular pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.762
H-Index - 100
eISSN - 1533-4023
pISSN - 0160-2446
DOI - 10.1097/fjc.0000000000001162
Subject(s) - valsartan , medicine , ejection fraction , sacubitril , cardiology , sacubitril, valsartan , heart failure , pulmonary artery , blood pressure
There is increasing evidence supporting the efficacy of sacubitril/valsartan for treating left heart failure, but few studies have investigated its effects on right ventricular (RV) dysfunction. This study aimed to explore the effects of sacubitril/valsartan on RV dysfunction among patients with heart failure with reduced ejection fraction (HFrEF).